Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 StudyK V Papp, P Maruff, D M Rentz, et al.
Neurology|May 14, 2010
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical declineJ L O'Brien, K M O'Keefe, P S LaViolette, et al.
Optics Express|October 1, 2008
Improvement of conversion efficiency for multi-junction solar cells by incorporation of Au nanoclustersM D Yang, Y K Liu, J L Shen, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical TrialsO Langford, R Raman, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2017
Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 BatteriesR F Buckley, K P Sparks, K V Papp, et al.
Analytical Chemistry|March 19, 2011
Multifunctional nanoparticles for dual imagingZ Ali, A Z Abbasi, F Zhang, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
The Future of Anti-Amyloid TrialsP S Aisen, J Cummings, R Doody, et al.
Hippocampus|July 3, 2007
Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI studyB C Dickerson, S L Miller, D N Greve, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Longitudinal Trajectories of the Cognitive Function Index in the A4 StudyR E Amariglio, J D Grill, D M Rentz, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical TrialR Yaari, K C Holdridge, M Mancini, et al.
Pageof 7